Lillian Brown

infectious disease physician | epidemiologist | HIV prevention | Bay Area Sports fan | Mom | Views my own.

[Lillian Brown @lilbrownmd]

@ajlamesa I spent a week taking only public transit in Mexico City on my own with my 5 and 7 year old. So much more pleasant than the US experience even during rush hour.

[Paul Sax @PaulSaxMD]

Yesterday, at the International AIDS Conference (#AIDS2024) in Munich, we got one of those thrilling moments you hope for when attending a scientific conference -- but don't usually get!

Here's what happened. @LindaGailBekker @drmoupali
https://t.co/dAV7LvUMCj

[Lillian Brown @lilbrownmd]

Looking forward to PURPOSE-2 results in gender-diverse individuals! #preventionwithpurpose

[Lillian Brown @lilbrownmd]

Great write up of the PURPOSE-1 results by @PaulSaxMD highlighting the incredible results and the many innovative aspects of the trial design https://t.co/iscnXc1MmC

[IAC - the International AIDS Conference @AIDS_conference]

👏 @DTHF_SA’s @LindaGailBekker 🇿🇦 receives a standing ovation after presenting full results from the PURPOSE 1 study. The results confirm #lenacapavir demonstrated 100% efficacy for #HIV prevention in cisgender women.

[NEJM @NEJM]

In the PURPOSE 1 randomized, controlled trial involving women in South Africa & Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection. Full trial results: https://t.co/MMqEYZpszL

#AIDS2024

[AVAC @HIVpxresearch]

Zero is zero!!! Remarkable results of injectable lenacapavir for PrEP.

Now we must translate trial results into public health impact.

#AIDS2024 @LindaGailBekker @apha_sa @ICWEastAfrica

[IAC - the International AIDS Conference @AIDS_conference]

“The introduction of oral #PrEP has changed the lives of more than 6 million people globally who have accessed it.” - @iasociety Past President @LindaGailBekker 🇿🇦 #AIDS2024

[IAS - the International AIDS Society @iasociety]

📊 Today at #AIDS2024, Past IAS President @LindaGailBekker presents full results from PURPOSE 1 trial. The results confirm #lenacapavir demonstrated 100% efficacy for #HIV prevention in cisgender women.

Read IAS President & AIDS 2024 Int'l Co-Chair @ProfSharonLewin's statement.

[APHA @apha_sa]

When science listens to community it looks something like this. We Join the AWPCAB and The Purporse1 GGCAG in celebrating the science and most importantly the trial participants . #Purpose1 #Choice #AGYW #AWPCAB
https://t.co/UgD5NmcRHx

[Carlos del Rio @CarlosdelRio7]

Gilead's twice-yearly antiviral protected women from HIV infection. PURPOSE 1 study results seem to be fantastic. ⁦@statnews⁩ https://t.co/Z8r4CEp4A8

[Lillian Brown @lilbrownmd]

@TheNickFoy 😂😂😂

[Lillian Brown @lilbrownmd]

@ajlamesa I think this is a great idea and wish there were both higher age limits and a commitment by governments and tech companies to developing high quality secure methods for age verification

[HIV Medicine Association @HIVMA]

We are deeply saddened by the passing of Adaora Adimora, MD, MPH, FIDSA. We were incredibly fortunate for her dedication to @IDSAinfo & HIVMA.

[Sam Esfandiari @samesfandiari]

Can’t believe the Spurs took Wemby over Podz.

[Earvin Magic Johnson @MagicJohnson]

Today is World AIDS Day and after 32 years of living with HIV, I’m blessed to still be here! I’m proud of the progress made in HIV/AIDS research, medication, and funding. We still have a long way to go for a cure and in the fight against stigma in all communities, especially in Black and brown. There is no place in this world for discrimination against those living with HIV/AIDS. #WorldAIDSDay

[Lillian Brown @lilbrownmd]

lol...this is why my parents made sure I got my driver's license 3 days after I turned 16

[SwimSwam @swimswamnews]

And we wouldn’t have it any other way @LastWeekTonight

[Lillian Brown @lilbrownmd]

@khmayer1 @michael_traeger @JuliaLMarcus @douglaskrakower Great article! Really like the shift from stigmatizing language around “risky behavior” to affirming positive impacts of PrEP use

[Ken Mayer @khmayer1]

#PrEP uptake is suboptimal. One problem is the difficulty providers have in supporting their patients' #sexual well-being. @michael_traeger @JuliaLMarcus @douglaskrakower and I discuss how to prioritize patients' experiences in this week's @LancetHIV

https://t.co/TX3prIdSzH